155 related articles for article (PubMed ID: 32282334)
1. CK1δ as a potential therapeutic target to treat bladder cancer.
Lin YC; Chen MC; Hsieh TH; Liou JP; Chen CH
Aging (Albany NY); 2020 Apr; 12(7):5764-5780. PubMed ID: 32282334
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel 7
Liu YM; Chen CH; Yeh TK; Liou JP
Future Med Chem; 2019 May; 11(9):959-974. PubMed ID: 30789758
[No Abstract] [Full Text] [Related]
3. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
4. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
[TBL] [Abstract][Full Text] [Related]
5. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
[TBL] [Abstract][Full Text] [Related]
6. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
7. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
Li J; Li Y; Meng F; Fu L; Kong C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
[TBL] [Abstract][Full Text] [Related]
9. Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
Hänze J; Kessel F; Di Fazio P; Hofmann R; Hegele A
Biomed Pharmacother; 2018 Oct; 106():316-325. PubMed ID: 29966976
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits bladder cancer progression via regulation of β-catenin expression.
Shi J; Wang Y; Jia Z; Gao Y; Zhao C; Yao Y
Tumour Biol; 2017 Jul; 39(7):1010428317702548. PubMed ID: 28705118
[TBL] [Abstract][Full Text] [Related]
11. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
13. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
14. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
Li Y; Zu X; Hu X; Wang L; He W
Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897
[TBL] [Abstract][Full Text] [Related]
15. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
[TBL] [Abstract][Full Text] [Related]
16. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
[TBL] [Abstract][Full Text] [Related]
17. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
19. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
20. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]